CD8A and breast cancer: In a recent study in a mouse model of 4T1 BC, a combination of anti-PD-1 antibody and DBDx (dipyridamole, betadine and dexamethasone) was found to result in lower Treg ratios in peripheral blood and tumors, and higher CD8+ T/Treg ratios after treatment [158].